Thrombolytic and Hypotensive Properties of Kallikrein in Anaesthetized Cats

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1988; 60(02): 344
DOI: 10.1055/s-0038-1647060

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

J Swies

The Institute of Pharmacology, N. Copernicus Academy of Medicine, 31-531 Kraków, Poland
L Grodzińska

The Institute of Pharmacology, N. Copernicus Academy of Medicine, 31-531 Kraków, Poland
M Slawiński

The Institute of Pharmacology, N. Copernicus Academy of Medicine, 31-531 Kraków, Poland
R J Gryglewski

The Institute of Pharmacology, N. Copernicus Academy of Medicine, 31-531 Kraków, Poland

Received 02 May 1988

Accepted after revision 16 May 1988

Publication Date:
28 June 2018 (online)

References
1 Gryglewski RI, Korbut R, Ocetkiewicz A, Stachura J. In vivo method of quantification of auliplatelet potency of drugs. Naunyn-Schmiedebergs Arch Pharmacol 1978; 304: 45-50

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Gryglewski RJ, Moncada S, Palmer RMJ. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aorta endothelium cells. Br J Pharmacol 1986; 87: 685-694

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Furchgott RFA. The role of endothelium in the responses of vascular smooth muscle to drug. Rev Pharmacol 1984; 24: 175-197

Reference Link Ris
PubMed Search in Google Scholar